Early research (Phase 1)Study completedNCT03000257What this trial is testingBudigalimab (ABBV-181) in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors AbbVie 182
Testing effectiveness (Phase 2)Study completedNCT00333502What this trial is testingStudy of CRLX101 (NLG207) in the Treatment of Advanced Solid TumorsWho this might be right forCancerSolid Tumor NewLink Genetics Corporation 62
Not applicableWithdrawnNCT04034745What this trial is testingOpen Label Study to Analyze the Effect of Telotristat Ethyl on Weight Regulation/GainWho this might be right forPancreatic CancerNeuroendocrine TumorsCachexia; Cancer Andrew Hendifar, MD
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT03037385What this trial is testingPhase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid TumorsWho this might be right forRET-altered Non Small Cell Lung CancerMedullary Thyroid CancerRET-altered Papillary Thyroid Cancer+37 more Hoffmann-La Roche 590
Early research (Phase 1)Looking for participantsNCT06479811What this trial is testing[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck CancersWho this might be right forHead and Neck TumorsKidney CancersSmall Cell Lung Cancers+3 more National Cancer Institute (NCI) 120
Testing effectiveness (Phase 2)UnknownNCT02294006What this trial is testingActivity and Safety of Everolimus+Octreotide LAR+Metformin in Advanced Pancreatic Well-differentiated NETsWho this might be right forWell Differentiated Pancreatic Endocrine Tumor Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 26
Not applicableStudy completedNCT06171945What this trial is testingMobile Weight Loss Intervention for Adolescent and Young Adult Cancer SurvivorsWho this might be right forCancerPhysical ActivityCancer Survivorship+2 more UNC Lineberger Comprehensive Cancer Center 63
Not applicableStudy completedNCT00745381What this trial is testingA Collection of Clinical and Epidemiologic Data Combined With Tissue and Blood From Patients With a Diagnosis of Neuroendocrine TumorsWho this might be right forGastric CancerPancreatic Cancer Memorial Sloan Kettering Cancer Center 238
Not applicableUnknownNCT03517332What this trial is testingCirculating Tumor DNA Exposure in Peripheral BloodWho this might be right forColorectal CancerPancreatic AdenocarcinomaGastric Cancer+8 more Quantgene Inc. 10,000
Testing effectiveness (Phase 2)Looking for participantsNCT06953089What this trial is testingDB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid TumorsWho this might be right forSolid Tumors DualityBio Inc. 492
Not applicableStudy completedNCT05528614What this trial is testingEvaluation of the Results of Simultaneous Pancreatic and Hepatic Resections for Metastatic Neuroendocrine Tumors.Who this might be right forTumor of Pancreas University Hospital, Strasbourg, France 51
Testing effectiveness (Phase 2)Looking for participantsNCT07371663What this trial is testingAn Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid TumorsWho this might be right forSolid CancersNSCLC (Advanced Non-small Cell Lung Cancer)Gastric (Stomach) Cancer+2 more Beijing Tide Pharmaceutical Co., Ltd 266
Not applicableNo Longer AvailableNCT01980732What this trial is testing68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive TumorsWho this might be right forCarcinoid TumorsIslet Cell (Pancreatic NET)Other Neuroendocrine Tumors Andrei Iagaru
Early research (Phase 1)WithdrawnNCT06626256What this trial is testingSTIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and MelanomaWho this might be right forLocally Advanced Cervical CarcinomaLocally Advanced Colorectal CarcinomaLocally Advanced Malignant Solid Neoplasm+24 more City of Hope Medical Center
Early research (Phase 1)Ended earlyNCT05831995What this trial is testingSafety and Effectiveness of ABM-168 in Adults with Advanced Solid Tumors.Who this might be right forAdvanced Solid TumorRAS MutationRAF Mutation+1 more ABM Therapeutics Corporation 12
Early research (Phase 1)Study completedNCT00804336What this trial is testingPasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine TumorsWho this might be right forNeuroendocrine TumorCarcinoid TumorPancreatic Neuroendocrine Tumor Dana-Farber Cancer Institute 22
Not applicableLooking for participantsNCT05539677What this trial is testingBiobank and Register of Patients With Agresive Tumors for Translational and Analytical ResearchWho this might be right forMalignant Solid TumorsPrimary Brain TumorMelanoma+4 more N.N. Petrov National Medical Research Center of Oncology 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT05086692What this trial is testingA Beta-only IL-2 ImmunoTherapY StudyWho this might be right forAdvanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more Medicenna Therapeutics, Inc. 115
Early research (Phase 1)Ended earlyNCT05909995What this trial is testingInterventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid TumorsWho this might be right forMelanomaHepatocellular Carcinoma (HCC)Renal Cell Carcinoma (RCC)+3 more Incyte Corporation 8